VANCOUVER, June 29 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today that the
There are currently 162 Fellowship Programs operating in the US. CRH is making this same educational program available to each of these Fellowship Programs. The Company believes that a partnership between itself and gastroenterologists allow for an outstanding continuum of care for patients.
About CRH Medical Corporation:
CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.
USA Gastroenterology is an academic division of the Department of Medicine whose mission is teaching, research, and patient care. The division is responsible for teaching gastrointestinal, nutritional, and hepatology physiology and pathophysiology to medical students, residents, and fellows, as well as to attending physicians for continuing education. Supervised consultation concerning digestive disorders is available throughout the Academic Health Center at USA Medical Center, Infirmary West, USA Children's and Women's Hospital, and their private practice located within the Digestive Health Center at Infirmary West.
The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
|SOURCE CRH Medical Corporation|
Copyright©2009 PR Newswire.
All rights reserved